Level 1 ATC classes by share of public drug plan costs Canada 2021/2022

In fiscal year 2021/2022, the nervous system was the third ranked level 1 ATC therapeutic class by share of total drug costs with 11 percent. This statistic depicts the top 10 level 1 ATC therapeutic classes by share of total drug costs in FY 2021/2022. ATC stands for the Anatomical Therapeutic Chemical (ATC) classification system as it is maintained by the World Health Organization.

Leading level 1 ATC therapeutic classes by share of total drug costs in select Canadian public drug plans in 2021/2022

Characteristic	Share of total drug costs
Antineoplastic and immunomodulating agents	28.4%
Alimentary tract and metabolism	15.4%
Nervous system	11%
Cardiovascular system	7.1%
Sensory organs	6.9%
Respiratory system	6.6%
Blood and blood forming organs	5.9%
Antiinfectives for systemetic use	5.5%
Musculo-skeletal system	3%
Genito-urinary system and sex hormones	1.9%

Loading statistic...

Download

Source

Show detailed source information?

Already a member?

Sources

Use Ask Statista Research Service

Release date

2023

More information

Region

Canada

Survey time period

fiscal year 2021/2022

Supplementary notes

The therapeutic classes reported are the level 1 category of the World Health Organization’s Anatomical Therapeutic and Chemical (ATC) classification system. The public drug plans include British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, New Brunswick, Nova Scotia, Prince Edward Island, Newfoundland and Labrador, Yukon, and the Non-Insured Health Benefits Program.

Citation formats